Clincosm LogoSign in Get a demo

Compliance With American Diabetes Association Treatment Guidelines for Adult Ketoacidosis

Sponsor
Marshall University (Other)
Overall Status
Unknown status
CT.gov ID
NCT00589680
Collaborator
(none)
60
Enrollment
1
Location
7
Duration (Months)
8.6
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

At this time, Saint Mary's Medical Center is currently in the process of implementing a standardized diabetic ketoacidosis (DKA) protocol. The first main goal of this project will be to evaluate patient outcomes to determine the effects of treating patients without a standardized protocol and to establish a baseline on how patients are being treating with DKA. The final goal of the project will be to compare outcomes of those patients not placed on the protocol to those that were treated using SMMC newly implemented DKA protocol. The overall goal of this project is to determine the benefit of an institutional DKA protocol.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    60 participants
    Time Perspective:
    Retrospective
    Official Title:
    Compliance With American Diabetes Association Treatment Guidelines for Adult Ketoacidosis
    Study Start Date :
    Dec 1, 2007
    Anticipated Primary Completion Date :
    Jul 1, 2008
    Anticipated Study Completion Date :
    Jul 1, 2008

    Arms and Interventions

    Arm Intervention/Treatment
    2

    Patients treated for DKA under DKA protocol implemented by hospital
    1

    To establish a baseline on how patients are being treating with DKA in general and without a standardized DKA protocol

    Outcome Measures

    Primary Outcome Measures

    1. Hospital length of stay [Time in hospital]

    Secondary Outcome Measures

    1. ICU length of stay [hospital stay]

    2. ICU length of stay Hypoglycemic events (BG<60) [hospital stay]

    3. Time to correction of glucose level and anion gap [hospital stay]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • Admitted to St. Mary's Medical Center with DKA

    • /= 18 years of age

    Exclusion Criteria:
    • < 18 years of age

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 St. Mary's Medical Center Huntington West Virginia United States 25702

    Sponsors and Collaborators

    • Marshall University

    Investigators

    • Principal Investigator: Sharon Jones, Pharm.D., St. Mary's Medical Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00589680
    Other Study ID Numbers:
    • 9137
    First Posted:
    Jan 10, 2008
    Last Update Posted:
    Jan 10, 2008
    Last Verified:
    Dec 1, 2007
    Keywords provided by , ,
    Acidosis, Diabetic
    Diabetic Acidosis
    Diabetic Ketosis
    Ketoacidosis, Diabetic
    Ketosis, Diabetic
    Additional relevant MeSH terms:
    Ketosis
    Acidosis
    Diabetic Ketoacidosis

    Study Results

    No Results Posted as of Jan 10, 2008